VALTREX
- Product NDC
- 55289-926
- 11-digit product format
- 552890926
- Labeler code
- 55289
- Product ID
- 55289-926_7bbcacd0-85df-18b0-e053-2a91aa0a7fc1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- valacyclovir hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- NDA020487
- Marketing category
- NDA
- Marketing start
- 1995-08-01
- Marketing end
- 0000-00-00
- Substance
- VALACYCLOVIR HYDROCHLORIDE
- Active strength
- 500 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 55289-926 | D | Discontinued by firm | 2026-07-31 | ||
| excluded package | package | 55289-926 | 55289-926-04 | D | Discontinued by firm | 2026-07-31 | |
| excluded package | package | 55289-926 | 55289-926-06 | D | Discontinued by firm | 2026-07-31 | |
| excluded package | package | 55289-926 | 55289-926-07 | D | Discontinued by firm | 2026-07-31 | |
| excluded package | package | 55289-926 | 55289-926-08 | D | Discontinued by firm | 2026-07-31 | |
| excluded package | package | 55289-926 | 55289-926-10 | D | Discontinued by firm | 2026-07-31 | |
| excluded package | package | 55289-926 | 55289-926-14 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020487-001 | VALTREX | VALACYCLOVIR HYDROCHLORIDE | EQ 500MG BASE | TABLET / ORAL | AB | RLD | 1995-06-23 |
| N020487-002 | VALTREX | VALACYCLOVIR HYDROCHLORIDE | EQ 1GM BASE | TABLET / ORAL | AB | RLD | 1995-06-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N020487-001 | AB |
| N020487-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N020487-001 | VALTREX | EQ 500MG BASE | TABLET / ORAL | AB | RLD | 1995-06-23 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N020487-002 | VALTREX | EQ 1GM BASE | TABLET / ORAL | AB | RLD | 1995-06-23 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N020487-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N020487-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VALTREX | VALACYCLOVIR HYDROCHLORIDE | REMEDYREPACK INC. | 56a62c21-bead-4f3b-a24e-c3fd0b4a732f | 2026-07-16 | Warnings, Adverse reactions | 020487 NDA020487 |
| VALTREX | VALACYCLOVIR HYDROCHLORIDE | GlaxoSmithKline LLC | f8e0d8f8-cb73-4206-a484-88f5c4fbd719 | 2025-11-12 | Warnings, Adverse reactions | 020487 NDA020487 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-926-04 | EA - Each | 55289-926 | afbe7d47-f7a2-4446-9e9a-27095136fba6 | 1 | 2012-07-24 |
| 55289-926-06 | EA - Each | 55289-926 | 298138e9-adfa-4ac6-9e1f-a9faceb42915 | 1 | 2012-07-24 |
| 55289-926-07 | EA - Each | 55289-926 | 0864b548-73d0-4eb8-8469-c578323cca90 | 1 | 2012-07-24 |
| 55289-926-08 | EA - Each | 55289-926 | 77f05aca-163e-4bec-a6f0-b4011757395c | 1 | 2012-07-24 |
| 55289-926-10 | EA - Each | 55289-926 | 91e61fe6-dadf-496e-838a-d8bfd2ec8b6d | 1 | 2012-07-24 |
| 55289-926-14 | EA - Each | 55289-926 | 115ac1dd-6050-491b-907a-6ca989322a31 | 1 | 2012-07-24 |